Evaluation of a Proactive Clinical Management and Early Diagnosis of Arrhythmias in Patients With Heart Failure and Non Severely Reduced Left Ventricular Function Through a Telemonitoring System
- Conditions
- Heart FailureArrhythmias, Cardiac
- Interventions
- Device: implantable loop recorder
- Registration Number
- NCT05974306
- Lead Sponsor
- Leonardo Calò, MD
- Brief Summary
Vasco trial is a no profit, multicenter, international, prospective, randomized study designed to evaluate the clinical benefits of a remote monitoring management based on ILR vs standard practice in patients with high risk of cardiac arrhythmias, heart failure and left ventricle ejection fraction (LVEF)\> 40% .The study will enroll about 331 patients (221 in the ILR group and 110 in the in-hospital follow-up group).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 331
- Patients with heart failure, LVEF> 40% who report episodes of palpitations.
- Over 18 years of age
- Ability to provide informed consent for registry participation and be willing and able to comply with the protocol described evaluations
- Subject who is, or is expected to be unavailable for follow-up
- Pregnancy
- Medical contraindications for ILR implantation
- Patients with PMK / ICD or with Indication for ICD / PMK implantation
- Cardiovascular events / myocardial revascularization in the previous three months
- Patients already on oral anticoagulant treatment
- Patients who do not want to use the telemonitoring system
- Presence of other recognized indications to ILR (Unexplained syncope, cryptogenic stroke/TIA, Transient loss of consciousness and recurrent falls)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description ILR group implantable loop recorder patients implanted with an implantable loop recorder to be monitored remotely.
- Primary Outcome Measures
Name Time Method Evaluate the benefits of a remote monitoring management based on ILR vs standard practice in patients with high risk of cardiac arrhythmias, heart failure and LVEF> 40% in the detection of significant clinical events. 2 years Detection rate of arrhythmias that require treatment (medical or interventional)
- Secondary Outcome Measures
Name Time Method